What Lanmer does

Lanmer OÜ, founded in 2014 in Tartu, Estonia by Merlin Langel, is a private B2B services and distribution company that operates three interconnected divisions under the Lanmer Group umbrella: Lanmer CRO, Lanmer Distro, and Lanmer Hardware Venture Studio (HVS) with its flagship Langel Labs innovation facility. Lanmer CRO delivers full-service clinical trial management, regulatory affairs support (EU CTR/CTIS, MDR, IVDR, CE-marking), medical writing, patient recruitment, and quality assurance across all EU member states, the Balkans, Türkiye, the Middle East, and Africa, operating through a senior network of regional specialists rather than full-time employees in each geography. Lanmer Distro distributes laboratory and medical equipment, consumables, and instruments from global manufacturers including Thermo Fisher Scientific, Benchmark Scientific, and Singer Instruments to research laboratories, healthcare institutions, and manufacturers in the Baltic and Nordic regions, supplemented by installation, maintenance, repair, training, lab design, and compliance consulting services.

Lanmer's core technology footprint is largely distributional rather than proprietary — the company does not develop laboratory instruments or software platforms. Its principal internally built assets are Langel Labs, a purpose-built R&D infrastructure supporting molecular biology, nanomaterial research, nanoformulation, and biospecimen analysis, and an integrated multi-division ecosystem that connects clinical operations, equipment distribution, and deep-tech venture support under a single corporate brand. The company generates revenue through three streams: hardware sales and lifecycle services (Distro), professional services contracts for clinical research (CRO), and consulting/advisory fees plus investment facilitation for hardware and biotech ventures (HVS). Pricing is not publicly disclosed; all engagements are consultation-driven, with quotes tailored to project scope. Target customers are enterprise clients — pharmaceutical and biotechnology sponsors, medical device and diagnostic developers, research laboratories, healthcare institutions, and deep-tech startups in the Baltic, Nordic, and broader European/CIS-adjacent regions. The company holds ISO 9001:2015 certification covering its equipment sales, consultation, installation, maintenance, and repair activities.

The business is led by a small core team (1–10 employees per firmographic data), anchored by CEO Merlin Langel (17+ years of clinical research and regulatory experience across ICON plc, Optimapharm, Comac Medical, and Crown CRO) and Senior Advisor Päivi Itkonen (30+ years, former Director of Clinical Research for Nordics and Baltics at Quintiles and founder/CEO of Crown CRO Oy prior to its acquisition by Optimapharm). No external funding rounds, institutional investors, or revenue figures are disclosed in the available materials.

Name

Lanmer

Legal name

Lanmer OÜ

Website

https://lanmer.eu

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Lanmer OÜ is a Tartu, Estonia-based B2B services company operating three divisions: Lanmer CRO (clinical research and regulatory affairs across Europe and emerging markets), Lanmer Distro (laboratory and medical equipment distribution in the Baltics and Nordics), and Lanmer Hardware Venture Studio (deep-tech innovation support via its Langel Labs facility), serving pharma, biotech, medical device, and research clients.

Ownership category

akta.pro rank

Product category

Laboratory Equipment Distribution & Clinical Research Services

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Medical Laboratories (8071), Wholesale-Hardware (5072), Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Clinical research services
• Laboratory equipment distribution
• Medical device distribution
• Regulatory affairs consulting
• Deep tech venture studio

Headquarters

HQ city

Vahi

HQ country

Estonia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Laboratory & Medical Equipment Distribution: Lanmer Distro distributes cutting-edge laboratory equipment, medical devices, and consumables from world-leading manufacturers like Thermo Fisher Scientific. Revenue is generated through product sales, consultation services, installation, maintenance, and repair services. The company has established partnerships with leading global manufacturers to bring high-quality technologies to the Baltic and Nordic regions.
2. Clinical Research Services: Lanmer CRO provides full-service clinical research operations including clinical trial management, regulatory submissions, medical writing, patient recruitment, site monitoring, and quality assurance. Services span from EU CTR/CTIS regulated studies to non-CTIS territories. Revenue generated through project-based professional services contracts with pharmaceutical, biotechnology, and medical device sponsors.
3. Hardware Venture Studio Advisory & Consulting: Lanmer HVS provides advisory services for deep-tech and hardware development including project planning for advanced facilities, business development, go-to-market strategies, manufacturing scale-up consulting, medical device regulatory compliance (EU MDR, IVDR, CE-marking), and public/private investment facilitation. Revenue generated through consulting fees and partnership arrangements.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Lanmer Group is a multidisciplinary B2B organization operating three interconnected divisions: Lanmer CRO provides full-service clinical trial management, regulatory affairs, medical writing, patient recruitment, and quality assurance across Europe and emerging regions; Lanmer Distro distributes laboratory and medical equipment, consumables, and related installation, maintenance, and consultation services from global manufacturers such as Thermo Fisher Scientific; Lanmer Hardware Venture Studio delivers advisory, regulatory compliance (EU MDR/IVDR), go-to-market strategy, and investment facilitation for deep-tech startups, anchored by the Langel Labs R&D infrastructure.

Product overview

Lanmer Group is a multidisciplinary organization comprising three interconnected divisions: Lanmer CRO (Clinical Research Organization providing full-service clinical trial management and regulatory support across Europe and emerging regions), Lanmer Distro (medical and laboratory equipment distribution with consultation services covering laboratory supplies, medical research tools, manufacturing equipment, and installation/maintenance services), and Lanmer Hardware Venture Studio (supporting deep-tech and hardware development with advisory, infrastructure access, and investment facilitation through its Langel Labs innovation laboratory). The company operates as a portfolio of specialized sub-brands offering consultation-driven solutions rather than a unified software platform.

Differentiator

Problem solved

Functional benefit

Brands

• Lanmer CRO: Clinical Research and Regulatory Operations - European full-service CRO providing clinical trial management, regulatory support, and operations across Europe, Balkans, Türkiye, and Africa.
• Lanmer Distro
• Lanmer Hardware Venture Studio (HVS)
• Langel Labs

Products and services

• Lanmer CRO Full-service Clinical Research Organization providing clinical trial management, regulatory affairs, medical writing, patient recruitment, site monitoring, and quality assurance for pharmaceutical, biotechnology, and medical-device sponsors across all EU member states, the Balkans, Türkiye, Middle East, and Africa.
• Lanmer Distro Distribution and consultation division supplying medical and laboratory equipment, consumables, and lab infrastructure to research laboratories and healthcare institutions across the Baltic and Nordic regions, with installation, maintenance, repair, and warranty services. Partners with Thermo Fisher Scientific and other global manufacturers.
• Lanmer Hardware Venture Studio (HVS) Advisory and venture studio platform supporting deep-tech and hardware development through project planning for advanced facilities, business development, go-to-market strategy, manufacturing scale-up consulting, medical device regulatory compliance (EU MDR, IVDR, CE-marking), investment facilitation, and custom innovation programs.
• Langel Labs Innovation laboratory and flagship initiative of Lanmer Hardware Venture Studio providing modern R&D infrastructure, analytical capabilities, and expert collaboration for startups, research institutions, and industrial partners across molecular biology, nanomaterial research, nanoformulation, and biospecimen analysis.

Quantifiable outcome

• Reduced development cycles and accelerated time-to-market through tailored project management and commercialization strategy
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

13 partnerships are on record, tiered core, secondary and minor.

• Thermo Fisher ScientificcoreChannel Partner/ Reseller/ DistributorThermo Fisher Scientific is listed as an Industry & Corporate Partner. Lanmer Distro distributes Thermo Fisher Scientific products including laboratory equipment, instruments, and consumables across the Baltic and Nordic regions. The partnership provides access to comprehensive portfolio of laboratory solutions for research, diagnostics, and manufacturing.
• TehnopolcoreStrategic or Co-development PartnerTehnopol, a Public & Innovation Programs partner, collaborates with Lanmer on innovation ecosystem development and startup support programs in Estonia. Tehnopol is a prominent innovation hub supporting technology ventures and research commercialization.
• University of TartucoreStrategic or Co-development PartnerUniversity of Tartu is listed as an Academic & Research Institution partner. The partnership provides collaboration opportunities for technology translation, joint research, and access to academic expertise in the biotechnology and life sciences sectors.
• TalTechsecondaryStrategic or Co-development PartnerTalTech (Tallinn University of Technology) is listed as an Academic & Research Institution partner, providing potential collaboration on research projects, technology development, and talent access for deep-tech innovation initiatives.
• QPScoreStrategic or Co-development PartnerQPS is listed as a Clinical & Regulatory Partner. QPS is a global contract research organization specializing in preclinical and clinical trial services, enabling collaboration on clinical research operations and regulatory affairs.
• Tartu Biotechnology ParkcoreStrategic or Co-development PartnerTartu Biotechnology Park is an Academic & Research Institution partner that strengthens Lanmer's position in the Baltic biotechnology ecosystem and provides access to regional research infrastructure and expertise.
• Horizon EuropecoreStrategic or Co-development PartnerHorizon Europe is listed as a partnership for Regional and EU Project Participation, enabling Lanmer HVS to engage in collaborative research and innovation projects funded by the European Union's research and innovation program.
• Enterprise Estonia (EIS)secondaryStrategic or Co-development PartnerEnterprise Estonia supports Lanmer through national innovation programs and business development initiatives, providing access to funding opportunities and regional innovation ecosystem resources.
• Singer InstrumentssecondaryChannel Partner/ Reseller/ DistributorSinger Instruments is listed as a partner, with Lanmer distributing their products including specialized instruments for synthetic biology and laboratory applications.
• TBD PharmatechminorStrategic or Co-development PartnerTBD Pharmatech is listed as a partner, representing potential collaboration in pharmaceutical technology development and commercialization.
• IcosagenminorStrategic or Co-development PartnerIcosagen is listed as a partner, providing potential collaboration opportunities in biotechnology research and development services.
• GSD DiagnosticsminorChannel Partner/ Reseller/ DistributorGSD Diagnostics is listed as a partner, representing potential distribution or collaboration in diagnostic solutions and testing technologies.
• Estonian Genome CentreminorStrategic or Co-development PartnerEstonian Genome Centre is listed as an Academic & Research Institution partner, providing potential collaboration on genetic research and genomic data projects.

Scale indicators4 records

Recent moves3 records

Broad incumbents

• IQVIA: Largest global CRO and life-science technology provider (former Quintiles); Senior Advisor Päivi Itkonen previously led clinical research for Nordics and Baltics at Quintiles, making it the dominant incumbent against which Lanmer CRO is benchmarked.
• Avantor: Global distributor of laboratory supplies and equipment (including the VWR brand), competing directly with Lanmer Distro at the manufacturer-distribution interface, particularly for lab consumables and instruments in Europe.
• Eurofins Scientific: Global leader in bioanalytical and clinical laboratory testing services with deep European footprint; comparable to Lanmer's positioning at the intersection of lab services, equipment and clinical research support.
• Medpace: Mid-to-large global CRO focused on Phase II–III trials with growing European operations, competing for the same biotech and mid-pharma sponsors as Lanmer CRO.
• Thermo Fisher Scientific (Laboratory Products & Services): World-leading manufacturer whose products Lanmer Distro distributes and which can sell direct or through competing channel partners; the strategic principal whose channel decisions materially shape Lanmer's distribution opportunity.
• Charles River Laboratories: Global CRO with strong discovery, safety assessment and clinical operations; competing for the same biotech and pharma sponsors targeting European clinical programs that Lanmer CRO pursues.
• ICON plc: Global top-3 CRO offering Phase I–IV clinical trial management and regulatory services; a former employer of Lanmer's founder and the dominant scale competitor whose strategic moves (e.g., PRA acquisition) shape the addressable market.

Direct peers

• Comac Medical: Mid-sized CRO specializing in Central and Eastern Europe with comparable Phase I–IV clinical trial and regulatory services; also a former employer of Lanmer's CEO, making it a closely comparable regional peer.
• BioNordika: Nordics- and Baltics-focused distributor of life science reagents, instruments and consumables — the closest regional functional analogue to Lanmer Distro, with overlapping manufacturer relationships and customer base in research and clinical labs.
• Optimapharm: European full-service CRO with a strong CEE and Nordics footprint and direct overlap with Lanmer CRO; Optimapharm is also a former employer of CEO Merlin Langel and acquired Crown CRO (founded by Lanmer advisor Päivi Itkonen).

Market position

Strengths4 records

Weaknesses4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lanmer